Can late gadolinium enhancement on cardiovascular magnetic resonance describe cardiac involvement in patients with systemic sarcoidosis and/or suspect of cardiac involvement of sarcoidosis with cardiac symptoms?

Ngā tūemi rite

• Can late gadolinium enhancement on cardiovascular magnetic resonance describe cardiac involvement in patients with systemic sarcoidosis and/or suspect of cardiac involvement of sarcoidosis with cardiac symptoms?
  mā: Shuji Sakai, me ētahi atu.
  I whakaputaina: (2011-02-01)
• Value of late gadolinium enhancement by magnetic resonance in patients with cardiac sarcoidosis: characteristic findings and clinical utility
  mā: Kawana Masatoshi, me ētahi atu.
  I whakaputaina: (2009-01-01)
• T2-weighted short-tau-inversion-recovery imaging reflects disease activity of cardiac sarcoidosis
  mā: Kengo Kusano, me ētahi atu.
  I whakaputaina: (2021-12-01)
• Is subendocardial or transmural late gadolinium enhancement able to differentiate between dcm and icm on cardiac mri?
  mā: Kawana Masatoshi, me ētahi atu.
  I whakaputaina: (2010-01-01)
• Cardiac sarcoidosis
  mā: Luca Arcari, me ētahi atu.
  I whakaputaina: (2026-03-01)